DNA Script is listed on the portfolio pages of EQT Partners (portfolio page) and Eurazeo (portfolio page). EQT Partners and Eurazeo list it as current. Eurazeo has owned DNA Script since 2019, per Eurazeo's portfolio page.
DNA Script is a Life Sciences company. Its owner on record, EQT Partners, is a private equity firm founded in 1994, headquartered in Stockholm, Sweden, with €266 billion ($285 billion) under management. EQT Partners lists 358 companies in the index, 104 of them in Life Sciences. Also backed by Eurazeo.
EQT AB is a leading Swedish global investment organization that manages a variety of investment funds across several asset classes.
Read the EQT Partners profileEurazeo is a leading French private equity firm and investment group that manages a diversified portfolio of over 600 companies.
Read the Eurazeo profileDNA Script is listed on the portfolio pages of EQT Partners (portfolio page) and Eurazeo (portfolio page). EQT Partners and Eurazeo list it as current. Eurazeo has owned DNA Script since 2019, per Eurazeo's portfolio page.
DNA Script is in Life Sciences. Classified from the owner's portfolio label.
EQT Partners is headquartered in Stockholm, Sweden.
EQT Partners lists 103 other Life Sciences companies in the index, including 3Shape, Aerska, Agomab Therapeutics, AIG Hospitals and Am-Pharma.
6 of 357 shown
See the full EQT Partners portfolio.
6 of 265 shown
See the full Eurazeo portfolio.
Browse PE-backed companies.
